Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy: Efficacy, Tolerability, Dosing Equivalence, and Retention Rate
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Mar 2019
Price : $35 *
At a glance
- Drugs Clobazam (Primary) ; Clonazepam
- Indications Epilepsy
- Focus Therapeutic Use
- 07 Mar 2019 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Mar 2017)
- 07 Mar 2019 Last checked against ClinicalTrials.gov record.
- 01 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Sep 2017.